Naz Rahman
Stock Analyst at Maxim Group
(0.05)
# 4,388
Out of 4,405 analysts
456
Total ratings
33.4%
Success rate
-11.6%
Average return
Main Sectors:
Stocks Rated by Naz Rahman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GLMD Galmed Pharmaceuticals | Maintained: Hold | $0.55 | $0.612 | -10.13% | 13 | Jun 10, 2026 | |
| ACOG Alpha Cognition | Reiterated: Buy | $12 | $5.99 | +100.33% | 2 | Jun 10, 2026 | |
| NVCT Nuvectis Pharma | Reiterated: Buy | $17 | $10.71 | +58.73% | 12 | Jun 10, 2026 | |
| KZIA Kazia Therapeutics | Rated: Buy | $20 → $30 | $14.28 | +110.08% | 13 | Jun 4, 2026 | |
| CING Cingulate | Reiterated: Buy | $8 | $4.88 | +63.93% | 27 | Jun 3, 2026 | |
| VRTX Vertex Pharmaceuticals | Reiterated: Buy | $575 | $444.93 | +29.24% | 33 | Jun 2, 2026 | |
| EPA: ADOC Adocia SA | Reiterated: Buy | €16.00 | $4.28 | +273.83% | 6 | May 22, 2026 | |
| NXGL NEXGEL | Reiterated: Buy | $2 | $0.551 | +262.98% | 33 | May 19, 2026 | |
| TLPH Talphera | Reiterated: Buy | $3 | $0.8734 | +243.49% | 13 | May 15, 2026 | |
| AYTU Aytu BioPharma | Rated: Buy | $7 | $2.15 | +225.58% | 20 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $5.84 | +242.47% | 33 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $22 → $24 | $23.48 | +0.09% | 13 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $1.10 | +263.64% | 24 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $4.20 | +852.38% | 32 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 | $28.75 | +143.48% | 36 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 | $3.13 | +1,816.93% | 22 | Apr 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $1.5 | $0.44 | +240.91% | 1 | Apr 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $1.71 | +367.84% | 30 | Apr 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $1.5 | $0.3779 | +296.93% | 1 | Feb 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $2.17 | - | 15 | Nov 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $0.7352 | - | 24 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $0.007 | n/a | 11 | Dec 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $1.36 | n/a | 21 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $0.00001 | n/a | 11 | May 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $5.35 | n/a | 6 | Aug 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $5.27 | n/a | 3 | Jan 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 | $8.21 | n/a | 1 | Aug 12, 2021 |
Galmed Pharmaceuticals
Jun 10, 2026
Maintained: Hold
Price Target: $0.55
Current: $0.612
Upside: -10.13%
Alpha Cognition
Jun 10, 2026
Reiterated: Buy
Price Target: $12
Current: $5.99
Upside: +100.33%
Nuvectis Pharma
Jun 10, 2026
Reiterated: Buy
Price Target: $17
Current: $10.71
Upside: +58.73%
Kazia Therapeutics
Jun 4, 2026
Rated: Buy
Price Target: $20 → $30
Current: $14.28
Upside: +110.08%
Cingulate
Jun 3, 2026
Reiterated: Buy
Price Target: $8
Current: $4.88
Upside: +63.93%
Vertex Pharmaceuticals
Jun 2, 2026
Reiterated: Buy
Price Target: $575
Current: $444.93
Upside: +29.24%
Adocia SA
May 22, 2026
Reiterated: Buy
Price Target: €16.00
Current: $4.28
Upside: +273.83%
NEXGEL
May 19, 2026
Reiterated: Buy
Price Target: $2
Current: $0.551
Upside: +262.98%
Talphera
May 15, 2026
Reiterated: Buy
Price Target: $3
Current: $0.8734
Upside: +243.49%
Aytu BioPharma
May 15, 2026
Rated: Buy
Price Target: $7
Current: $2.15
Upside: +225.58%
May 15, 2026
Reiterated: Buy
Price Target: $20
Current: $5.84
Upside: +242.47%
May 14, 2026
Maintained: Hold
Price Target: $22 → $24
Current: $23.48
Upside: +0.09%
May 14, 2026
Reiterated: Buy
Price Target: $4
Current: $1.10
Upside: +263.64%
May 8, 2026
Reiterated: Buy
Price Target: $40
Current: $4.20
Upside: +852.38%
May 1, 2026
Reiterated: Buy
Price Target: $70
Current: $28.75
Upside: +143.48%
Apr 28, 2026
Reiterated: Buy
Price Target: $60
Current: $3.13
Upside: +1,816.93%
Apr 20, 2026
Initiated Coverage: Buy
Price Target: $1.5
Current: $0.44
Upside: +240.91%
Apr 1, 2026
Reiterated: Buy
Price Target: $8
Current: $1.71
Upside: +367.84%
Feb 24, 2026
Initiated Coverage: Buy
Price Target: $1.5
Current: $0.3779
Upside: +296.93%
Nov 19, 2025
Maintained: Hold
Price Target: n/a
Current: $2.17
Upside: -
Aug 7, 2025
Maintained: Hold
Price Target: n/a
Current: $0.7352
Upside: -
Dec 18, 2024
Maintained: Buy
Price Target: n/a
Current: $0.007
Upside: n/a
Nov 20, 2024
Maintained: Hold
Price Target: n/a
Current: $1.36
Upside: n/a
May 17, 2023
Maintained: Hold
Price Target: n/a
Current: $0.00001
Upside: n/a
Aug 10, 2022
Maintained: Hold
Price Target: n/a
Current: $5.35
Upside: n/a
Jan 13, 2022
Maintained: Hold
Price Target: n/a
Current: $5.27
Upside: n/a
Aug 12, 2021
Maintained: Buy
Price Target: $6
Current: $8.21
Upside: n/a